Melissa A Jim
Overview
Explore the profile of Melissa A Jim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Melkonian S, Jim M, Haverkamp D, Lee M, Janitz A, Campbell J
Cancer Epidemiol Biomarkers Prev
. 2024 May;
33(8):1065-1072.
PMID: 38727561
Background: Non-Hispanic American Indian and Alaska Native (NH-AI/AN) people exhibit a disproportionate incidence of kidney cancer. Nationally aggregated data do not allow for a comprehensive description of regional disparities in...
2.
Townsend J, Melkonian S, Jim M, Holman D, Buffalo M, Julian A
JAMA Dermatol
. 2023 Dec;
160(2):148-155.
PMID: 38150212
Importance: Non-Hispanic American Indian/Alaska Native people have the second highest incidence rate of invasive cutaneous melanoma in the US after non-Hispanic White people. Objective: To examine invasive cutaneous melanoma incidence...
3.
Melkonian S, Jim M, Reza A, Peipins L, Haverkamp D, Said N, et al.
Am J Epidemiol
. 2023 Oct;
193(1):58-74.
PMID: 37823258
Social determinants of health and associated systems, policies, and practices are important drivers of health disparities. American Indian and Alaska Native (AI/AN) populations in the United States have elevated incidence...
4.
Melkonian S, Chen L, Jim M, Haverkamp D, King J
Cancer Causes Control
. 2023 May;
34(8):671-672.
PMID: 37202565
No abstract available.
5.
Melkonian S, Chen L, Jim M, Haverkamp D, King J
Cancer Causes Control
. 2023 May;
34(8):657-670.
PMID: 37126144
Purpose: This study is the first to comprehensively describe incidence rates and trends of screening-amenable cancers (colorectal, lung, female breast, and cervical) among non-Hispanic AI/AN (NH-AI/AN) people. Methods: Using the...
6.
Melkonian S, Said N, Weir H, Jim M, Siegel D
Ann Epidemiol
. 2023 Apr;
83:78-86.e2.
PMID: 37119997
Purpose: Studies have highlighted geographic variation in cancer incidence rates among American Indian and Alaska Native (AI/AN) populations. This is the first study to comprehensively evaluate incidence rates and trends...
7.
Pete D, Erickson S, Jim M, Hatcher S, Echo-Hawk A, Dominguez A
Am J Public Health
. 2022 Sep;
112(10):1489-1497.
PMID: 36103693
To evaluate COVID-19 disparities among non-Hispanic American Indian/Alaska Native (AI/AN) and non-Hispanic White persons in urban areas. Using COVID-19 case surveillance data, we calculated cumulative incidence rates and risk ratios...
8.
Melkonian S, Jim M, Pete D, Poel A, Dominguez A, Echo-Hawk A, et al.
Cancer
. 2022 Feb;
128(8):1626-1636.
PMID: 35119703
Background: Disparities in cancer incidence have not been described for urban American Indian/Alaska Native (AI/AN) populations. The purpose of the present study was to examine incidence rates (2008-2017) and trends...
9.
Haverkamp D, Melkonian S, Jim M
Cancer Epidemiol Biomarkers Prev
. 2021 Aug;
30(10):1799-1806.
PMID: 34341050
Background: American Indian and Alaska Native (AI/AN) populations have experienced regional variation and disparities in colorectal cancer incidence rates. Methods: We examined colorectal cancer incidence (2013-2017) and colorectal cancer incidence...
10.
Melkonian S, Weir H, Jim M, Preikschat B, Haverkamp D, White M
Am J Epidemiol
. 2021 Jan;
190(4):528-538.
PMID: 33506248
Cancer incidence varies among American Indian and Alaska Native (AI/AN) populations, as well as between AI/AN and White populations. This study examined trends for cancers with elevated incidence among AI/AN...